Srs Capital Advisors, Inc. Novo Cure LTD Transaction History
Srs Capital Advisors, Inc.
- $8.6 Billion
- Q3 2025
A detailed history of Srs Capital Advisors, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 34,746 shares of NVCR stock, worth $393,324. This represents 0.01% of its overall portfolio holdings.
Number of Shares
34,746
Previous 1,870
1758.07%
Holding current value
$393,324
Previous $33,000
1257.58%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NVCR
# of Institutions
292Shares Held
74.8MCall Options Held
1.26MPut Options Held
247K-
Black Rock Inc. New York, NY12.1MShares$137 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$118 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT9.64MShares$109 Million7.58% of portfolio
-
State Street Corp Boston, MA2.61MShares$29.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.47MShares$28 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.19B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...